Answers are grounded in this paper and cite their sources.
This guideline provides direction for clinicians regarding screening and treatment decisions for management of lupus nephritis. These recommendations should not be used to limit or deny access to therapies, as treatment decisions may vary due to the unique clinical situation and personal preferences of each individual patient.
No takes yet. Share an insight, caveat, or question.
Sammaritano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: